GLP-1 receptor agonist medications suppress appetite by targeting neural signaling pathways that regulate hunger and body weight settling points

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.

Supports users in reaching and maintaining a healthy body weight through behavioral and nutritional tools.